Trademarkia Logo

Australia

AU$
ALLOCAR
Cancelled: Cancelled at the request of IB

Last updated on 5 May 2023

Owner Info

Allogene Therapeutics, Inc.

210 E. Grand Avenue

South San Francisco CA 94080, UNITED STATES OF AMERICA

Serial Number

2004343 filed on 14 Mar 2019

Correspondent

Jason S. Howell Perkins Coie LLP

1201 Third Avenue, Suite 4900,

Seattle WA 98101,

UNITED STATES OF AMERICA

ALLOCAR

Classification Information


Class [005]
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immuno Read More

Mark Details


Serial Number

2004343

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

18 Sept 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
5th May 2023Status change to Voided
13th Jan 2023International Registration in Australia Refused correspondence sent
11th Jan 2023Status change to Lapsed/Not Protected
10th Jan 2023Refused to Grant Extension of Time correspondence sent
16th Dec 2022Intention to Refuse to Grant an Extension of Time correspondence sent
9th Nov 2022Adverse Report (Extension of Time) correspondence sent
8th Nov 2022Adverse Issues Response Received
7th Nov 2022General Request Initiated
5th Oct 2022General Correspondence sent
5th Oct 2022Adverse Report (Extension of Time) correspondence sent